Symbol Lookup

Sunday March 01, 2015 7:27 AM ET. Data delayed 15 minutes.
0.04
-0.01 (-17.95%)
Bid/Lots
0.00/0
Ask/Lots
0.00/0
Open/Prev Close
0.04/0.04
Day Range
0.04-0.04
52-Week Range
0.01-0.25
Vol/Avg Daily Vol
735.3K/817.2K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
USPTO Issues Notice of Allowance in Connection With CardioGenics' Self-Metering Cartridge Patent Application
9:50AM ET on Tuesday Feb 17, 2015 by GlobeNewswire

CardioGenics Holdings Inc. (OTCQB:CGNH), developer of the ultra-sensitive QL Care(TM) analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics ("IVD") testing market, announced today that the United State...

Company Information

CardioGenics Holdings Inc. is a Canada-based development-stage company. The Company develops technology and products targeting the immunoassay segment of the in vitro diagnostic (IVD) testing market. The Company‚Äôs products include: QL Care Analyzer (QLCA), Cardiovascular Tests and Paramagnetic Beads.  The QLCA represents a shift in the design of point-of-care (POC) analyzers. To support the use of the QLCA, the Company has developed four immunoassay tests designed to identify cardiac markers in the blood at the time of a heart attack. These tests include Troponin I (TnI), Plasminogen Activator Inhibitor Type-1 (PAI-1), Heart Failure Risk Stratification (HFRS) and Heart Failure Genomics Risk (HFGR).  Pramagnetic (magnetic) beads are the common solid phase employed during immunoassays tests in these laboratories. The Company has developed a process that coats the beads with a layer of silver, making them white and more sensitive to light.

CONTACT INFORMATION

Headquarters6865 SW 18th St Ste B13
BOCA RATON, FL, United States 33433-7057
Phone905-673-8501
Fax--

EXECUTIVE OFFICERS

Acting Independent Chairman of the BoardJ.Neil Tabatznik
Chief Executive Officer, DirectorYahia Gawad
Chief Financial OfficerJames Essex
Corporate Secretary, DirectorLinda Sterling
Independent DirectorKarim Murabet

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$2.1MBeta1.10
Revenue (TTM)$0.00EPS$-0.04
Shares Out.58.5MBook Value$-0.02
CardioGenics Holdings Inc does not pay a dividend.P/E--
Price/Sales (TTM)--
P/Cash Flow (TTM)--
Operating Margin--

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample